News - TopAbstracts in Ovarian Cancer 10/21/2009

	Unregistered User Click here if this is not your Personal Edition
		Contact Us \| Free E-Mail Updates \| Journals \| Register a colleague

Ovarian Cancer

EXPLORE :

Most Read News

All News

All Webcasts / CME

All Cases

Congress Resource Centre

All Medical Resources

My Personal Edition

Warning | Privacy

Recent news - Ovarian Cancer

	TopAbstracts in Ovarian Cancer 11/18/2009 - (DGNews)
	Neoadjuvant Chemotherapy Confers Important Benefits in Advanced Ovarian Cancer: Presented at ACS - (DGDispatch)
	Dose-Dense Chemotherapy Improves Survival in Advanced Ovarian Cancer - (DGNews)
	TopAbstracts in Ovarian Cancer 09/23/2009 - (DGNews)

News archive

Recent webcasts/CME - Ovarian Cancer

Expert Perspectives on Challenges, Controversies, and Opportunities in Ovarian Cancer Therapy: The Present and the Future
Taking Stock of the Current Research: Which New Therapies Are Showing Promise in Ovarian Cancer?
Q&A Lightning Round: Expert Opinions on Unanswered Questions and Controversies in Ovarian Cancer

Current Therapeutic Options and Clinical Issues in Recurrent Ovarian Cancer: Where Do We Stand?

Ovarian Cancer: Designed for the Primary Care Physician

Webcasts/CME archive

Recent cases - Ovarian Cancer

	Leser-Trelat Sign Presenting in a Patient with Ovarian Cancer: A Case Report
	Large Family with Both Parents Affected by Distinct BRCA1 Mutations: Implications for Genetic Testing
	Primary Hepatic Embryonal Sarcoma Masquerading as Metastatic Ovarian Cancer
	Choroidal Eye Metastases from (Recurrent) Primary Peritoneal Carcinoma: Case Report and Review of the Literature
	A Case of Meigs Syndrome Mimicking Metastatic Breast Carcinoma

Cases archive

my personal edition > ovarian cancer > news

E-Mail this item to a colleague

TopAbstracts in Ovarian Cancer 10/21/2009

10/21/2009

TopAbstracts™ in Ovarian Cancer are the abstracts most highly rated/most read by nearly 300,000 physicians who received a Doctor's Guide™ newsletter or visited a website Powered by Doctor's Guide™ in the past 28 days. Over 2000 peer-reviewed journals are covered by TopAbstracts.

TopAbstracts - Past 28 days

Dose-dense paclitaxel once a week in combination with carboplatin every 3 weeks for advanced ovarian cancer: a phase 3, open-label, randomised controlled trial - (Lancet)
The combination of monthly carboplatin and weekly paclitaxel is highly active for the treatment of recurrent ovarian cancer - (Gynecol Oncol)
Sustained progression-free survival with weekly paclitaxel and bevacizumab in recurrent ovarian cancer - (Gynecol Oncol)
Value of serum CA125 levels in patients with high-risk, early stage epithelial ovarian cancer - (Gynecol Oncol)
Outpatient platinum-taxane intraperitoneal chemotherapy regimen for ovarian cancer - (Int J Gynecol Cancer)

TopAbstracts - Past 3 months

Phase III Trial of Observation Versus Six Courses of Paclitaxel in Patients With Advanced Epithelial Ovarian Cancer in Complete Response After Six Courses of Paclitaxel/Platinum-Based Chemotherapy: Final Results of the After-6 Protocol 1 - (J Clin Oncol)
A review of the current evidence for maintenance therapy in ovarian cancer - (Gynecol Oncol)
Risk of ovarian cancer in women with symptoms in primary care: population based case-control study - (BMJ)
Neoadjuvant chemotherapy with carboplatin and docetaxel in advanced ovarian cancer - a prospective multicenter phase II trial (PRIMOVAR) - (Oncol Rep)
Intensity-Modulated Whole Abdominal Radiotherapy After Surgery and Carboplatin/Taxane Chemotherapy for Advanced Ovarian Cancer: Phase I Study - (Int J Radiat Oncol Biol Phys)

E-Mail this item to a colleague

To print, use this version